Literature DB >> 21945077

P190A RhoGAP is required for mammary gland development.

B M Heckman-Stoddard1, T Vargo-Gogola, M P Herrick, A P Visbal, M T Lewis, J Settleman, J M Rosen.   

Abstract

P190A and p190B Rho GTPase activating proteins (GAPs) are essential genes that have distinct, but overlapping roles in the developing nervous system. Previous studies from our laboratory demonstrated that p190B is required for mammary gland morphogenesis, and we hypothesized that p190A might have a distinct role in the developing mammary gland. To test this hypothesis, we examined mammary gland development in p190A-deficient mice. P190A expression was detected by in situ hybridization in the developing E14.5day embryonic mammary bud and within the ducts, terminal end buds (TEBs), and surrounding stroma of the developing virgin mammary gland. In contrast to previous results with p190B, examination of p190A heterozygous mammary glands demonstrated that p190A deficiency disrupted TEB morphology, but did not significantly delay ductal outgrowth indicating haploinsufficiency for TEB development. To examine the effects of homozygous deletion of p190A, embryonic mammary buds were rescued by transplantation into the cleared fat pads of SCID/Beige mice. Complete loss of p190A function inhibited ductal outgrowth in comparison to wildtype transplants (51% vs. 94% fat pad filled). In addition, the transplantation take rate of p190A deficient whole gland transplants from E18.5 embryos was significantly reduced compared to wildtype transplants (31% vs. 90%, respectively). These results suggest that p190A function in both the epithelium and stroma is required for mammary gland development. Immunostaining for p63 demonstrated that the myoepithelial cell layer is disrupted in the p190A deficient glands, which may result from the defective cell adhesion between the cap and body cell layers detected in the TEBs. The number of estrogen- and progesterone receptor-positive cells, as well as the expression levels of these receptors was increased in p190A deficient outgrowths. These data suggest that p190A is required in both the epithelial and stromal compartments for ductal outgrowth and that it may play a role in mammary epithelial cell differentiation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945077      PMCID: PMC3215776          DOI: 10.1016/j.ydbio.2011.09.006

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  46 in total

Review 1.  Control of normal mammary epithelial phenotype by integrins.

Authors:  C H Streuli; G M Edwards
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  The role of Rho GTPases in disease development.

Authors:  Benjamin Boettner; Linda Van Aelst
Journal:  Gene       Date:  2002-03-20       Impact factor: 3.688

Review 3.  RHO-GTPases and cancer.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

4.  p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.

Authors:  A Tikoo; S Czekay; C Viars; S White; J K Heath; K Arden; H Maruta
Journal:  Gene       Date:  2000-10-17       Impact factor: 3.688

5.  Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development.

Authors:  Raffaella Sordella; Marie Classon; Kang Quan Hu; Stephen F Matheson; Madeleine R Brouns; Barry Fine; Le Zhang; Hiroya Takami; Yoshihiko Yamada; Jeffrey Settleman
Journal:  Dev Cell       Date:  2002-05       Impact factor: 12.270

6.  Rho GTPases as modulators of the estrogen receptor transcriptional response.

Authors:  L F Su; R Knoblauch; M J Garabedian
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

7.  p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.

Authors:  Rebecca M Wolf; Nicole Draghi; Xiquan Liang; Chengkai Dai; Lene Uhrbom; Charlotta Eklöf; Bengt Westermark; Eric C Holland; Marilyn D Resh
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

8.  Cadherin engagement inhibits RhoA via p190RhoGAP.

Authors:  Nicole K Noren; William T Arthur; Keith Burridge
Journal:  J Biol Chem       Date:  2003-02-26       Impact factor: 5.157

9.  Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis.

Authors:  Karpagam Srinivasan; Phyllis Strickland; Ana Valdes; Grace C Shin; Lindsay Hinck
Journal:  Dev Cell       Date:  2003-03       Impact factor: 12.270

10.  Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.

Authors:  G Fritz; C Brachetti; F Bahlmann; M Schmidt; B Kaina
Journal:  Br J Cancer       Date:  2002-09-09       Impact factor: 7.640

View more
  9 in total

1.  The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.

Authors:  Pratima Basak; Rachelle Dillon; Heather Leslie; Afshin Raouf; Michael R A Mowat
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

Review 2.  Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.

Authors:  Aurélien Bidaud-Meynard; Fabien Binamé; Valérie Lagrée; Violaine Moreau
Journal:  Small GTPases       Date:  2017-03-13

3.  The RhoGEF Net1 is required for normal mammary gland development.

Authors:  Yan Zuo; Rebecca Berdeaux; Jeffrey A Frost
Journal:  Mol Endocrinol       Date:  2014-12

Review 4.  Minireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and Metastasis.

Authors:  Yan Zuo; Wonkyung Oh; Arzu Ulu; Jeffrey A Frost
Journal:  Mol Endocrinol       Date:  2015-12-17

5.  A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney Defects.

Authors:  Katherine Stewart; Yaned Gaitan; Maxwell E R Shafer; Lamine Aoudjit; Di Hu; Richa Sharma; Mathieu Tremblay; Hidetaka Ishii; Michael Marcotte; Daniela Stanga; You Chi Tang; Sami Kamel Boualia; Alana H T Nguyen; Tomoko Takano; Nathalie Lamarche-Vane; Silvia Vidal; Maxime Bouchard
Journal:  PLoS Genet       Date:  2016-02-09       Impact factor: 5.917

6.  p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth.

Authors:  Hanyue Ouyang; Phi Luong; Morten Frödin; Steen H Hansen
Journal:  Oncogene       Date:  2020-07-08       Impact factor: 9.867

Review 7.  p190RhoGAPs, the ARHGAP35- and ARHGAP5-Encoded Proteins, in Health and Disease.

Authors:  Capucine Héraud; Mathilde Pinault; Valérie Lagrée; Violaine Moreau
Journal:  Cells       Date:  2019-04-12       Impact factor: 6.600

8.  P190B RhoGAP Regulates Chromosome Segregation in Cancer Cells.

Authors:  Melissa Hwang; Sirisha Peddibhotla; Peter McHenry; Peggy Chang; Zachary Yochum; Ko Un Park; James Cooper Sears; Tracy Vargo-Gogola
Journal:  Cancers (Basel)       Date:  2012-04-25       Impact factor: 6.639

9.  A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans.

Authors:  Ayman M Ibrahim; Alan Bilsland; Steffen Rickelt; Joanna S Morris; Torsten Stein
Journal:  Breast Cancer Res       Date:  2021-09-26       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.